20 ML immunoglobulin G, human 200 MG/ML Injection [Hizentra]
RxNorm concept 1809067, branded drug (sbd). Prescribable name: Hizentra 20 % in 20 ML Injection.
- RxCUI
- 1809067
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1809067 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
20 ML Hizentra 200 MG/ML Injection; Hizentra 20 % per 20 ML Injection; Hizentra 4 GM per 20 ML Injection
Related concepts
- immunoglobulin G, human 200 MG/ML (SCDC, consists of)
- immunoglobulin G, human 200 MG/ML [Hizentra] (SBDC, consists of)
- Injection (DF, has dose form)
- Hizentra (BN, has ingredient)
- 20 ML immunoglobulin G, human 200 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1809067 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1809067 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1809067. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.